10 unchanged sentences
However, we seek fair compensation for Pfizer’s and BioNTech’s use of our patented technology that was developed with great effort and at great expense, without which their COVID-19 mRNA-LNP vaccines would not have been successful.
+Added: On July 10, 2023, Pfizer and BioNTech filed their answer to the complaint, affirmative defenses and counterclaims.
+Added: We and Genevant have yet to answer these counterclaims and no case schedule is yet in place.
+Added: A scheduling conference is set for August 28, 2023.
Patent Infringement Litigation vs.
5 unchanged sentences
The lawsuit does not seek an injunction or otherwise seek to impede the sale, manufacture or distribution of MRNA-1273.
−Removed: However, the Company seeks fair compensation for Moderna’s use of its patented technology that was developed with great effort and at great expense, without which Moderna’s COVID-19 vaccine would not have been successful.
+Added: However, we seek fair compensation for Moderna’s use of its patented technology that was developed with great effort and at great expense, without which Moderna’s COVID-19 vaccine would not have been successful.
On May 6, 2022, Moderna filed a partial motion to dismiss the claims “relating to Moderna’s sale and provision of COVID-19 vaccine doses to the U.S.
8 unchanged sentences
On March 16, 2023, the Court held a Rule 16 scheduling conference, and on March 21, 2023, the Court issued a scheduling order in the matter without setting a trial date.
+Added: On June 9, 2023, the parties extended the schedule for claim construction proceedings.
+Added: The claim construction hearing is currently scheduled for February 7, 2024.
+Added: Document discovery in the action is currently ongoing.
Acuitas Declaratory Judgment Lawsuit
12 unchanged sentences
Acuitas filed its opposition to the motion to dismiss on November 1, 2022, and we and Genevant filed our reply brief on November 16, 2022.
−Removed: The motion is now fully briefed.
+Added: The motion is now fully briefed and a status conference is set for August 9, 2023.
No case schedule is yet in place.
4 unchanged sentences
Litigation is inherently unpredictable.
−Removed: Although the ultimate resolution of these various matters cannot be determined at this time, we do not
−Removed: believe that such matters, individually or in the aggregate, will have a material adverse effect on our consolidated results of operations, cash flows, or financial condition.
+Added: Although the ultimate resolution of these various matters cannot be determined at this time, we do not believe that such matters, individually or in the aggregate, will have a material adverse effect on our consolidated results of operations, cash flows, or financial condition.
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.